Löhr HF - Search Results

1

Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.

Böcher WO, Herzog-Hauff S, Herr W, Heermann K, Gerken G, Meyer Zum Büschenfelde KH, Löhr HF. Böcher WO, et al. Among authors: lohr hf. Clin Exp Immunol. 1996 Jul;105(1):52-8. doi: 10.1046/j.1365-2249.1996.d01-732.x. Clin Exp Immunol. 1996. PMID: 8697635 Free PMC article.

2

In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C.

Löhr HF, Gerken G, Michel G, Braun HB, Meyer zum Büschenfelde KH. Löhr HF, et al. Gastroenterology. 1994 Nov;107(5):1443-8. doi: 10.1016/0016-5085(94)90548-7. Gastroenterology. 1994. PMID: 7523227

3

HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-alpha.

Löhr HF, Goergen B, Meyer zum Büschenfelde KH, Gerken G. Löhr HF, et al. J Med Virol. 1995 Aug;46(4):314-20. doi: 10.1002/jmv.1890460405. J Med Virol. 1995. PMID: 7595407

4

Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants.

Löhr HF, Weber W, Schlaak J, Goergen B, Meyer zum Buschenfelde KH, Gerken G. Löhr HF, et al. Hepatology. 1995 Jul;22(1):61-8. doi: 10.1002/hep.1840220110. Hepatology. 1995. PMID: 7601434

5

Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.

Löhr HF, Schlaak JF, Lohse AW, Böcher WO, Arenz M, Gerken G, Meyer Zum Büschenfelde KH. Löhr HF, et al. Hepatology. 1996 Dec;24(6):1416-21. doi: 10.1002/hep.510240619. Hepatology. 1996. PMID: 8938173

6

HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.

Höhler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Löhr HF, Schneider PM, Meyer zum Büschenfelde KH, Rittner C. Höhler T, et al. Among authors: lohr hf. J Hepatol. 1997 Mar;26(3):503-7. doi: 10.1016/s0168-8278(97)80414-x. J Hepatol. 1997. PMID: 9075656

7

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.

Löhr HF, Gerken G, Roth M, Weyer S, Schlaak JF, Meyer zum Büschenfelde KH. Löhr HF, et al. J Hepatol. 1998 Oct;29(4):524-32. doi: 10.1016/s0168-8278(98)80146-3. J Hepatol. 1998. PMID: 9824260

8

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.

Böcher WO, Herzog-Hauff S, Schlaak J, Meyer zum Büschenfeld KH, Löhr HF. Böcher WO, et al. Among authors: lohr hf. Hepatology. 1999 Jan;29(1):238-44. doi: 10.1002/hep.510290120. Hepatology. 1999. PMID: 9862872 Clinical Trial.

9

Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.

Löhr HF, Krug S, Herr W, Weyer S, Schlaak J, Wölfel T, Gerken G, Meyer zum Büschenfelde KH. Löhr HF, et al. Liver. 1998 Dec;18(6):405-13. doi: 10.1111/j.1600-0676.1998.tb00825.x. Liver. 1998. PMID: 9869395

10

The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response.

Schlaak JF, Tully G, Löhr HF, Gerken G, Meyer zum Büschenfelde KH. Schlaak JF, et al. Among authors: lohr hf. J Hepatol. 1999 Mar;30(3):353-8. doi: 10.1016/s0168-8278(99)80090-7. J Hepatol. 1999. PMID: 10190714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters